Medigen Biotechnology Corp (基亞), a specialty pharmaceutical company, on Friday announced plans to acquire a 68 percent stake in Winston Medical Supply Co (溫士頓) through share swap, as it aims to add more production capacity to manufacture a new drug for hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is a common type of liver cancer in Taiwan. Medigen is currently working on the phase-three clinical trials of the new drug for HCC, Muparfostat, formerly known as PI-88, for which the company expects to obtain regulatory approval next year.
The drug was selected by the Department of Health, now the Ministry of Health and Welfare, to apply for new drug certification simultaneously in both Taiwan and China under the cross-strait Economic Cooperation Framework Agreement.
“Apart from the production of the drug by Australia’s Progen Pharmaceuticals Ltd, we expect to manufacture it at Winston’s factory to supply Taiwan, China and neighboring countries,” Medigen said in a filing to the Taiwan Stock Exchange on Friday.
Medigen reached a deal with Progen in 2010 to jointly develop and produce PI-88. The company is almost finished recruiting 500 people in Taiwan, South Korea, China and Hong Kong for the phase-three trials of the drug.
According to information on Winston’s Web site, the Greater Tainan-based company is constructing a new factory in Yungkang District (永康), which is to meet the standards set by the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme.
Medigen said the deal would also allow it to benefit from Winston’s domestic distribution network and sales expertise, after they jointly bring the PI-88 to the local market.
Under the deal, each of Medigen’s 2 million new shares will be exchanged for nine of Winston’s shares, the Taipei-based company said in the filing.
The share swap is expected to be completed on Jan. 10, if the deal receives the go-ahead from the Financial Supervisory Commission.
Medigen reported NT$66.88 million (US$2.27 million) in sales during the first 10 months of the year, down 23.97 percent year-on-year, with net losses expanding to NT$123.9 million in the first half of the year, from NT$115.3 million during the same period of last year, data showed.
Shares of Medigen fell by 1 percent to NT$198 in trading on Friday ahead of the announcement of the share swap deal.
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to